Assessment of indomethacin oral spray for the treatment of oropharyngeal mucositis-induced pain during anticancer therapy
Supportive Care in Cancer Sep 08, 2017
Momo K, et al. - This study strived to assess the efficacy and safety of indomethacin (IM) oral spray (OS) as a pain control therapy for oropharyngeal mucositis due to anticancer chemo- and radiotherapy in patients with head and neck carcinomas and haematological tumours. For pain relief, the present IM spray was an effective and safe preparation. For oropharyngeal mucositis in cancer patients, it could be used as an alternative therapeutic option.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries